References
Lindholm D, Mäkelä J, Di Liberto V, Mudò G, Belluardo N, Eriksson O, Saarma M. (2015) Current disease modifying approaches to treat Parkinson’s disease. Cell Mol Life Sci. 2015 Nov 30 [Epub ahead of print]
Brotchie J, Jenner P (2011) New approaches to therapy. Int Rev Neurobiol 98:123–150. doi:10.1016/B978-0-12-381328-2.00005-5
Segura-Aguilar J, Paris I, Muñoz P, Ferrari E, Zecca L, Zucca FA (2014) Protective and toxic roles of dopamine in Parkinson’s disease. J Neurochem 129:898–915. doi:10.1111/jnc.12686
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Segura-Aguilar, J., Paris, I. & Muñoz, P. The need of a new and more physiological preclinical model for Parkinson’s disease. Cell. Mol. Life Sci. 73, 1381–1382 (2016). https://doi.org/10.1007/s00018-016-2140-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-016-2140-2